Bioinformatics analysis suggests that overexpression of SLC12A5 inhibits the proliferation of glioma U251MG cells, and SLC12A5 may be a novel effective biomarker of GBM with prognostic significance [29]. This evidence concerns the gene SLC12A5 and central nervous system cancer.